Disparities exist in treatment, survival among black, white men with early stage breast cancer
the ONA take:
In this study, the researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer in men age 18 to 64 years and men 65 years and older.
The study included 725 non-Hispanic black (black) and 5,247 non-Hispanic white (white) men with a diagnosis of early stage breast cancer from 2004 to 2011 in the National Cancer Data Base.
Receipt of treatment was found to be remarkably similar between blacks and whites in both age groups. In both races, fewer older men received chemotherapy compared with younger men.
Risk of death, however, was higher for the younger black men than the younger white men, but the difference was significantly less after adjustments for covariates. That risk was not significant and not affected by covariates in the groups of older men.
Higher risk of death in black men vs white men is limited to men age 18 to 64 years and became nonsignificant after adjustments for insurance and income.
The researchers conclude that improving access to care is an important factor in reducing the disparities in male breast cancer mortality.
Researchers investigated the disparities between blacks and whites in receipt of treatment for early stage breast cancer.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- A Witness to Letting Go: Nursing Care at the End of Life
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Intervention Improves Breast Cancer Survivors' Memory Contentment
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Patients With Head and Neck Cancer Have Greater Chance of Being Prescribed Opioids
- Medical Terms in Patient Education: Using the Confusing to Explain the Complicated
- Bedside Assessment Tool Improves Worst Pain in Patients With Cancer
- Androgen-Deprivation Therapy for Prostate Cancer May Cause Nocturia, Sleep Disturbance
- USPSTF Rates Ovarian Cancer Screening a D for Asymptomatic, Low-Risk Women
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|